PU
Pulmatrix, Inc.
PULM · NASDAQ
$1.48 -0.66% (-$0.01)
1M -11.46%
Market Cap $4.97M
P/E Ratio -
Div. Yield -
ROE 109.26%
Piotroski F-Score Weak
1/9Valuation
89 /100
Cheap P/B 1.94x
P/E N/A
EV/EBITDA N/A
Growth
0 /100
Declining Book val. growth 50.34%
EPS growth N/A
Rev. growth N/A
Profitability
-
N/A Gross margin N/A
Net margin N/A
Op. margin N/A
Quality
0 /100
Poor ROIC 160.81%
ROE 109.26%
ROA 123.63%
Debt
100 /100
Low Debt/Equity 0.00x
Current ratio 4.70x
Int. coverage N/A
Stability
31 /100
Unstable Beta 1.90x
Rev. volatility 65.91%
EPS volatility 9.22%
Bulios Scoring popisuje kvalitu a minulost firmy, ne budoucí výnos. Vysoké skóre není nákupní signál. Zjistit více
Zeptejte se StockBota na PULM
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Peter Ludlum
Employees
2
Headquarters
Framingham
Nadcházející události
05 LIS
Earnings
Upcoming earnings report